XML 20 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]    
Revenues $ 20,555 $ 40,862
Cost of revenues (including depreciation of $15 and $50 in the years ended December 31, 2024 and 2023, respectively) 6,126 10,559
Gross profit 14,429 30,303
Operating expenses:    
Selling and marketing 8,877 11,089
Research and development 14,085 17,145
General and administrative 10,583 12,779
Depreciation and amortization 6,285 7,345
Goodwill impairment 23,989 0
Total operating expenses 63,819 48,358
Operating loss (49,390) (18,055)
Other income (expense):    
Change in fair value of warrant and derivative liabilities 372 4,214
Loss on derecognition of debt 0 (3,991)
Interest income (expense), net 112 (6,354)
Other income (expense), net 196 (52)
Loss before provision for income tax (benefit) provision (48,710) (24,238)
(Benefit) provision for income tax expense (13) 158
Net loss $ (48,697) $ (24,396)
Loss per share:    
Basic (in dollars per share) $ (3.94) $ (3.01)
Diluted (in dollars per share) $ (3.94) $ (3.01)
Weighted average shares outstanding:    
Basic (in shares) 12,367 8,115
Diluted (in shares) 12,367 8,115